Medicortex Finland
Develops biomarker-based diagnostic tests for traumatic brain injury and concussion
Highlights
- New on EvolcAdded 2026-10-30
About Medicortex Finland
Medicortex Finland develops a biomarker-based diagnostic test for traumatic brain injury (TBI) and concussion. Its research also includes potential treatments for TBI, including a drug development program.
The company is based in Turku and was founded in June 2014. It reports receiving grants from Finnish and European public programs, the U.S. Department of Defense, and private investors.
Product: A handheld diagnostic kit in development to detect traumatic brain injury and concussion using a proprietary biomarker.
Jobs at Medicortex Finland
No open positions listed right now.
More biotech & pharma companies
Misvik Biology
Cancer drug screening and preclinical research services for biopharma companies and academic institutionsNew on EvolcNadmed
NAD and glutathione assay kits and laboratory analysis for clinical and research laboratoriesYoung companyNew on EvolcNMR Solutions
NMR data analysis software and interpretation services for organizations using proton NMR spectroscopyNew on EvolcOmgenis
Develops a single-use periodontal bone reconstruction system for dental and periodontal careYoung companyNew on EvolcOrigin by Ocean
Bio-based fucoidan and alginate ingredients from invasive Sargassum for cosmetics, food and technical product formulatorsNew on EvolcOriola
Pharmaceutical and health product distribution, wholesale and advisory services for suppliers and pharmacies in the NordicsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- PHP
- WordPress
- nginx